Status:
COMPLETED
Insulin Resistance in Patients With Mood Disorder
Lead Sponsor:
Stanford University
Conditions:
Depression
Bipolar Disorder
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Insulin resistance is known to be associated with mood disorders and cognitive difficulties. The purpose of this study is to treat depressed patients with rosiglitazone (also known as \[AKA\] Avandia)...
Detailed Description
An association between insulin resistance (IR) and affective disorders has been postulated in a number of cross-sectional studies. Limited data exist on potential changes in IR associated with improve...
Eligibility Criteria
Inclusion
- Current depression
- Insulin resistance
- Current physician/psychiatrist care
- Between the ages of 18-60
- Willing to sign the Human Subjects Protection Consent Form
- Willing to have blood sampling
Exclusion
- Diabetes
- History of unstable heat disease
- Uncontrolled hypertension
- Extensive use of alcohol
- Current use of street drugs
- History of myocardial infarction
- History of cerebrovascular disease
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00242619
Start Date
July 1 2007
End Date
December 1 2009
Last Update
February 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305